SCOPUS 정보 검색 플랫폼

Volumn 27, Issue 12, 2000, Pages 2731-2733

The cost of COX inhibitors: How selective should we be?

(4) Marra, C A a Esdaile, J M a Sun, H a Anis, A H a

a UNIVERSITY OF BRITISH COLUMBIA (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; ETANERCEPT; INFLIXIMAB; LEFLUNOMIDE; NONSTEROID ANTIINFLAMMATORY AGENT; ROFECOXIB;

CANADA; DRUG COST; HEALTH CARE COST; HEALTH INSURANCE; OSTEOARTHRITIS; PRESCRIPTION; PRIORITY JOURNAL; REIMBURSEMENT; REVIEW; RHEUMATOID ARTHRITIS;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, RHEUMATOID; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DRUG COSTS; DRUG UTILIZATION; HEALTH CARE COSTS; HUMANS; ISOENZYMES; MEMBRANE PROTEINS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;

EID: 0033673062 PISSN: 0315162X EISSN: None Source Type: Journal
DOI: None Document Type: Review

Times cited : (17)

References (15)

1
- 0006934595
- Ottawa: The Institute
- (2000) Health care in Canada 2000: A first annual report

2
- 0003427510
- Ottawa: The Institute
- (1999) National health expenditure trends, 1975-1999

3
- 0034701084
- Pharmaceutical policies in Canada: Another example of provincial-federal discord
- (2000) CMAJ , vol.162 , pp. 523-526
- Anis, A.H.¹

4
- 4243213296
- Pointe-Claire: IMS Health
- (1999) Canadian pharmaceutical industry review, 1999

5
- 0006896722
- Available from: Pharmacy Benefits Management Strategic Healthcare Group, Department of Veterans Affairs via the Internet. Accessed 30 August
- (2000) Criteria for use of COX-II inhibitors in veteran patients

6
- 0034084131
- Analysis of the effect of COX-2 specific inhibitors and recommendations for their use in clinical practice
- (2000) J Rheumatol , vol.27 , pp. 1338-1340
- Lipsky, P.E.¹ Abramson, S.B.² Breedveld, F.C.³

7
- 0034090391
- Cost-effectiveness of non-steroidal anti-inflammatory drugs (NSAIDs) - What makes a NSAID good value for money
- (2000) Br J Rheumatol , vol.39 , pp. 232-234
- Freemantle, N.¹

8
- 0034644396
- Gastrointestinal toxicity with celecoxib vs nonsteroidal antiinflammatory drugs for OA and RA: The CLASS study: A randomized controlled trial
- (2000) JAMA , vol.284 , pp. 1247-1255
- Silverstein, F.E.¹ Faich, G.² Goldstein, J.L.³

9
- 0033601084
- COX-1 sparing NSAIDs - Is the enthusiasm justified?
- (1999) JAMA , vol.282 , pp. 1961-1963
- Peterson, W.L.¹ Cryer, B.²

10
- 0033601089
- Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: A randomized controlled trial
- (1999) JAMA , vol.282 , pp. 1921-1928
- Simon, L.S.¹ Weaver, A.L.² Graham, D.Y.³

11
- 0034717664
- A randomized trial of the efficacy and tolerability of the COX-2 inhibitor rofecoxib vs ibuprofen in patients with osteoarthritis
- Rofecoxib/Ibuprofen Comparator Study Group
- (2000) Arch Intern Med , vol.160 , pp. 1781-1787
- Day, R.¹ Morrison, B.² Luza, A.³

12
- 0028806589
- Guidelines for the medical management of osteoarthritis. Part 1. Osteoarthritis of the hip
- (1995) Arthritis Rheum , vol.38 , pp. 1535-1540
- Hochberg, M.C.¹ Altman, R.D.² Brandt, K.D.³

13
- 0032558285
- North of England evidence based guideline development project: Summary guidelines for non-steroidal anti-inflammatory drugs versus basis analgesia in treating the pain of degenerative arthritis
- (1998) BMJ , vol.317 , pp. 526-530
- Eccles, M.¹ Freemantle, N.² Mason, J.³

14
- 0030737645
- Are rheumatoid arthritis patients more willing to accept non-steroidal drug treatment risks than osteoarthritis patients?
- (1997) Br J Rheumatol , vol.36 , pp. 470-472
- Bagge, E.¹ Traub, M.² Crotty, M.³

15
- 0003866632
- Ottawa: CCOHTA
- (1997) Guidelines for economic evaluations of pharmaceuticals: Canada. 2nd ed.

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.